See Richard Paxman comment on the Q2 report

Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

See Richard Paxman comment on the Q2 report

Earlier today, a live presentation was held for investors, analysts and the media. During the presentation, which was moderated by Maria Karlsson Osipova, equity analyst at Carnegie, Richard Paxman commented on the report.

https://youtu.be/QtGqNzAzYRM?t=0

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 6,000 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK), Houston, Texas (US) and Toronto, Ontario (CA).

The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.

Datum	2025-08-20, kl 10:30
Källa	MFN

Bifogade filer

See Richard Paxman comment on the Q2 report

LOGGA IN

Paxman

See Richard Paxman comment on the Q2 report